TRICARE beneficiaries taking certain maintenance drugs for diabetes or high cholesterol are now paying lower or no copayments as part of a pilot program. The Medication Adherence Pilot Program, launched on Feb. 1, will examine whether people are more likely to follow a medication treatment plan when those drugs are available at no-or-reduced cost. The program affects prescriptions purchased at in-network retail pharmacies and through the TRICARE Pharmacy Home Delivery. Two high-value medications were chosen for the pilot program: Lantus® Pens and Rosuvastatin, the generic version of Crestor®. Participation is automatic. The pilot program will run for up to five years. For more details, see this Military Advantage blog post.
For guides on TRICARE programs, visit the Military.com TRICARE section.
